PTPRC and neoplasm: Tumor-associated macrophages (TAMs, defined as CD45+CD11b+ F4/80+Ly6C−Ly6G−) were most abundant (avg 32.2%, median 31.7%), followed by Ly6Chi inflammatory monocytes (avg 19.5%, median 19.6%) (CD45+CD11b+Ly6ChiF4/80lo/−Ly6G−).